运动预处理通过MAM改善失血性休克后大鼠肠系膜淋巴管收缩性
为验证运动预处理(EP)是否通过线粒体相关内质网膜(MAM)改善失血性休克后肠系膜淋巴管收缩性,该研究对大鼠进行4周EP后诱导失血性休克,观察生存时间及体内外淋巴管收缩性,并测试MAM激动剂与抑制剂的作用。结果显示EP延长生存时间、改善淋巴管收缩性和反应性,改善淋巴平滑肌细胞MAM超微结构并降低VDAC1和IP3R1表达;2-APB(IP3R1抑制剂)或VBIT-12(VDAC1抑制剂)产生类似保护效应,而饮用含CdCl2(IP3R1激活剂)的水消除EP的有益作用。提示EP对失血性休克后淋巴管收缩性的保护作用通过改善淋巴平滑肌细胞MAM实现。
要点
- 大鼠失血性休克模型中,4周运动预处理(EP)延长生存时间并改善肠系膜淋巴管在体内和体外的收缩性与反应性。
- EP改善淋巴平滑肌细胞(LSMC)MAM超微结构,并降低肠系膜淋巴组织中VDAC1和IP3R1表达。
- 2-APB(IP3R1抑制剂)或VBIT-12(VDAC1抑制剂)可延长失血性休克大鼠生存时间、改善体内肠系膜淋巴管收缩性、减轻MAM超微结构损伤并降低LSMC中IP3R1或VDAC1表达。
- 饮用含CdCl2(IP3R1激活剂)的水消除EP对失血性休克的有益作用。
适用人群与场景
- 失血性休克大鼠模型;清醒大鼠在失血性休克后观察生存时间及肠系膜淋巴管收缩性。
处置流程与药物剂量
- 运动预处理(EP)持续4周。
- 2-APB(IP3R1抑制剂)或VBIT-12(VDAC1抑制剂)用于失血性休克大鼠,可延长生存时间、改善体内肠系膜淋巴管收缩性、改善MAM超微结构损伤并降低LSMC中IP3R1或VDAC1表达。
- 饮用含CdCl2(IP3R1激活剂)的水可消除EP对失血性休克的有益作用。
研究设计与关键结果
- 研究为大鼠实验:4周EP可延长失血性休克后生存时间,改善体内和体外肠系膜淋巴管收缩性与反应性,改善淋巴平滑肌细胞MAM超微结构,降低肠系膜淋巴组织中VDAC1和IP3R1表达。
- 2-APB(IP3R1抑制剂)或VBIT-12(VDAC1抑制剂)处理可延长失血性休克大鼠生存时间、改善体内肠系膜淋巴管收缩性、改善MAM超微结构损伤并降低LSMC中IP3R1或VDAC1表达。
- 饮用含CdCl2(IP3R1激活剂)的水消除EP对失血性休克的有益作用。
证据类型、等级与局限
- 证据类型:大鼠实验研究。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Restoration of mesenteric lymphatic microcirculation is crucial for alleviating severe hemorrhagic shock-induced death. Exercise preconditioning (EP) enhances adaptability and resistance to injury and disease. The mitochondria-associated endoplasmic reticulum membrane (MAM) plays a crucial role in the energy and information exchange between the two organelles. Therefore, we hypothesized that EP ameliorates mesenteric lymphatic contractility through MAM in rats following hemorrhagic shock, aiming to confirm that EP enhances resistance to hemorrhagic shock and further popularizes the idea that exercise is beneficial for health. To test this hypothesis, we observed the effects of EP for 4 weeks on survival time and mesenteric lymphatic contractility in conscious rats following hemorrhagic shock and further explored the effects of MAM agonists and inhibitors. The results showed that EP prolonged the survival time and improved the mesenteric lymphatic contractility and reactivity in vivo and in vitro in rats underwent hemorrhagic shock, ameliorated the MAM ultrastructure in lymphatic smooth muscle cells (LSMCs) and reduced the voltage-dependent anion channel 1 (VDAC1, a vital protein of MAM) and IP3R1 expressions in mesenteric lymphatic tissue. Importantly, treatment with 2-APB (IP3R1 inhibitor) or VBIT-12 (VDAC1 inhibitor) prolonged the survival time, improved mesenteric lymphatic contractility in vivo , ameliorated the MAM ultrastructure injury, and decreased the IP3R1 or VDAC1 expressions in LSMCs in rats following hemorrhagic shock. In contrast, the administration of drinking water containing CdCl 2 (IP3R1 activator) abolished the beneficial effect of EP on hemorrhagic shock. Taken together, the protective effect of EP on lymphatic contractility following hemorrhagic shock was achieved by improving MAM in LSMCs.
参考来源
- Zheng HN, Zhang H, Wang J, et al. EXERCISE PRECONDITIONING IMPROVES MESENTERIC LYMPHATIC CONTRACTILITY THROUGH MAM IN RATS FOLLOWING HEMORRHAGIC SHOCK. Shock. 2024. PMID: 39158573. doi:10.1097/SHK.0000000000002424
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。